ASP
TSX:ASP
Acerus Pharmaceuticals Corporation
- Stock
Last Close
0.36
26/01 15:39
Market Cap
2.77M
Beta: 1.03
Volume Today
1.25K
Avg: 1.30K
PE Ratio
−0.09
PFCF: −0.10
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 3.35M - | 4.27M 27.39% | 3.76M 11.95% | 3.37M 10.25% | 2.74M 18.73% | 2M 27.07% | 1.90M 4.83% | 3.46M 81.72% | |
average payables | 3.90M - | 932.50K 76.06% | 1.37M 47.29% | 1.41M 2.55% | 1.30M 8.02% | 1.20M 7.76% | 1.05M 12.13% | 2.08M 98.14% | |
average receivables | 903.50K - | 1.87M 107.25% | 3.57M 90.84% | 3.53M 1.34% | 1.48M 58.09% | 878.50K 40.54% | 1.05M 19.98% | 943K 10.53% | |
book value per share | 16.26 - | -2.13 113.12% | 10.17 576.44% | 4.84 52.41% | -0.06 101.14% | -8.77 15,805.68% | 2.16 124.63% | -3.38 256.65% | |
capex per share | -0.28 - | -0.68 142.66% | -0.06 91.25% | -0.19 - | -0.08 59.41% | -0.01 - | |||
capex to depreciation | -0.11 - | -0.32 194.37% | -0.03 90.06% | -0.13 - | -0.10 19.63% | -0.11 - | |||
capex to operating cash flow | -0.03 - | 0.76 2,381.02% | -0.02 102.90% | 0.04 - | 0.01 75.16% | 0.00 - | |||
capex to revenue | -0.07 - | -0.05 29.56% | -0.00 93.70% | -0.03 - | -0.03 9.70% | 0.02 - | |||
cash per share | 30.64 - | 5.50 82.06% | 4.33 21.17% | 2.58 40.41% | 2.97 15.21% | 4.01 34.70% | 6.26 56.19% | 0.28 95.51% | |
days of inventory on hand | 190.31 - | 267.96 40.81% | 309.02 15.32% | 333.23 7.84% | 88.60 73.41% | 247.98 179.89% | 419.19 69.04% | 1.50K 258.65% | |
days payables outstanding | 28.68 - | 81.67 184.79% | 131.48 60.97% | 135.69 3.20% | 48.72 64.09% | 167.98 244.79% | 197.18 17.39% | 1.00K 408.80% | |
days sales outstanding | 152.92 - | 41.82 72.65% | 77.65 85.68% | 104.33 34.37% | 55.07 47.22% | 62.38 13.28% | 492.50 689.47% | -37.27 107.57% | |
debt to assets | 0.78 - | 1.08 38.29% | 0.59 45.58% | 0.73 24.56% | 1.00 36.78% | 1.83 82.33% | 0.81 55.55% | 3.70 354.00% | |
debt to equity | 3.61 - | -13.03 460.50% | 1.44 111.02% | 2.76 92.38% | -237.96 8,716.46% | -2.20 99.07% | 4.37 298.52% | -1.37 131.34% | |
dividend yield | |||||||||
earnings yield | -0.19 - | -0.45 143.33% | 0.45 198.42% | -0.15 134.55% | -0.83 438.58% | -0.90 7.90% | -2.66 196.81% | -0.93 65.16% | |
enterprise value | 114.35M - | 21.63M 81.09% | 26.18M 21.06% | 57.97M 121.40% | 27.09M 53.26% | 32.24M 19.00% | 8.28M 74.31% | 57.97M 599.71% | |
enterprise value over ebitda | -6.20 - | -4.89 21.12% | 1.82 137.24% | -9.27 609.30% | -1.72 81.44% | -2.42 40.70% | -0.38 84.35% | -1.84 385.69% | |
ev to operating cash flow | 13.55 - | -21.16 256.17% | 8.15 138.53% | 585.51 7,080.91% | -4.42 100.75% | -2.83 35.90% | -0.37 86.81% | -2.47 559.54% | |
ev to sales | 26.51 - | 1.28 95.18% | 1.07 16.37% | 9.00 741.27% | 3.67 59.17% | 8.56 132.99% | 7.64 10.77% | -14.03 283.69% | |
free cash flow per share | 8.06 - | -1.56 119.40% | 2.62 267.41% | 0.08 96.91% | -4.95 6,215.62% | -7.86 58.69% | -15.15 92.82% | -3.07 79.75% | |
free cash flow yield | 0.07 - | -0.09 234.72% | 0.13 239.37% | 0.00 98.61% | -0.28 16,189.58% | -0.64 126.58% | -2.41 277.95% | -0.65 73.22% | |
graham net net | -24.42 - | -19.41 20.49% | -5.44 72.00% | -8.43 55.13% | -8.53 1.10% | -14.48 69.81% | -1.65 88.60% | -4.02 143.43% | |
graham number | 90.47 - | 19.40 78.56% | 46.04 137.33% | 27.86 39.49% | 4.25 84.73% | 46.65 996.32% | 28.49 38.93% | 18.30 35.76% | |
income quality | -0.37 - | 0.11 130.37% | 0.29 155.19% | -0.01 103.93% | 0.33 2,972.63% | 0.71 116.25% | 0.91 28.60% | 0.70 23.38% | |
intangibles to total assets | 0.48 - | 0.51 6.52% | 0.46 9.82% | 0.56 23.31% | 0.47 16.46% | 0.32 32.82% | 0.13 60.18% | 0.03 72.40% | |
interest coverage | -11.90 - | 1.22 110.22% | 17.16 1,310.39% | -18.79 209.47% | -13.08 30.40% | -6.79 48.09% | -13.70 101.88% | -20.12 46.80% | |
interest debt per share | 25.09 - | 9.22 63.27% | 6.00 34.87% | 4.04 32.70% | 7.26 79.76% | 14.89 105.07% | 6.70 55.02% | 3.28 50.98% | |
inventory turnover | 1.92 - | 1.36 28.98% | 1.18 13.29% | 1.10 7.27% | 4.12 276.11% | 1.47 64.27% | 0.87 40.84% | 0.24 72.12% | |
invested capital | 1.44 - | -3.27 326.17% | 0.53 116.18% | 0.77 46.12% | -116.72 15,212.84% | -1.57 98.66% | 2.61 266.69% | -0.91 134.77% | |
market cap | 121.60M - | 19.93M 83.61% | 24.93M 25.10% | 56.55M 126.83% | 22.64M 59.97% | 18.01M 20.43% | 9.19M 48.98% | 36.52M 297.42% | |
net current asset value | -21.67M - | -19.84M 8.45% | -3.11M 84.32% | -8.13M 161.40% | -9.27M 14.01% | -19.04M 105.33% | 212K 101.11% | -27.02M 12,843.87% | |
net debt to ebitda | 0.39 - | -0.38 197.72% | 0.09 122.64% | -0.23 360.04% | -0.28 25.29% | -1.07 277.43% | 0.04 103.87% | -0.68 1,744.97% | |
net income per share | -22.37 - | -7.84 64.97% | 9.27 218.22% | -7.13 176.93% | -14.59 104.71% | -11.03 24.43% | -16.70 51.43% | -4.40 73.65% | |
operating cash flow per share | 8.34 - | -0.89 110.64% | 2.68 401.69% | 0.08 96.97% | -4.76 5,980.62% | -7.78 63.41% | -15.15 94.74% | -3.06 79.81% | |
payables turnover | 12.73 - | 4.47 64.89% | 2.78 37.88% | 2.69 3.10% | 7.49 178.51% | 2.17 71.00% | 1.85 14.81% | 0.36 80.35% | |
receivables turnover | 2.39 - | 8.73 265.68% | 4.70 46.14% | 3.50 25.58% | 6.63 89.46% | 5.85 11.72% | 0.74 87.33% | -9.79 1,421.49% | |
research and ddevelopement to revenue | 2.10 - | 0.17 91.91% | 0.07 61.64% | 0.34 415.69% | 0.33 3.29% | 0.75 130.97% | 2.33 210.09% | -1.59 168.21% | |
return on tangible assets | -0.57 - | -0.62 8.87% | 0.69 211.27% | -0.90 230.29% | -2.11 135.03% | -1.53 27.64% | -1.65 7.64% | -3.63 120.56% | |
revenue per share | 4.26 - | 14.68 244.51% | 20.40 39.00% | 5.27 74.17% | 5.73 8.71% | 2.58 55.04% | 0.74 71.20% | -0.54 172.48% | |
roe | -1.38 - | 3.67 366.97% | 0.91 75.19% | -1.47 261.63% | 264.59 18,063.32% | 1.26 99.52% | -7.73 714.87% | 1.30 116.82% | |
roic | -1.47 - | 0.19 113.04% | 0.71 271.67% | -0.47 166.62% | -1.79 276.71% | -4.25 137.55% | 8.81 307.52% | -14.58 265.49% | |
sales general and administrative to revenue | 0.84 - | 1.42 68.62% | 5.17 264.16% | -1.70 132.87% | |||||
shareholders equity per share | 16.26 - | -2.13 113.12% | 10.17 576.44% | 4.84 52.41% | -0.06 101.14% | -8.77 15,805.68% | 2.16 124.63% | -3.38 256.65% | |
stock based compensation to revenue | 0.16 - | 0.03 78.82% | 0.01 67.59% | 0.09 716.82% | 0.06 33.41% | 0.05 23.26% | 0.60 1,190.47% | -0.26 143.95% | |
tangible asset value | -19.73M - | -17.47M 11.44% | -1.40M 91.98% | -6.64M 374.30% | -8.00M 20.45% | -17.72M 121.41% | 1.02M 105.74% | -26.35M 2,688.41% | |
tangible book value per share | -19.49 - | -15.16 22.20% | -1.17 92.30% | -5.44 365.57% | -6.22 14.38% | -12.11 94.87% | 0.70 105.74% | -3.43 592.53% | |
working capital | 25.90M - | -13.92M 153.75% | 5.94M 142.65% | 2.79M 53.01% | 1.96M 29.78% | 1.73M 11.89% | 6.93M 301.56% | -3.42M 149.40% |
All numbers in CAD (except ratios and percentages)